quotes and stock data delayed 15 minutes
Burn Rate (Qtr)
ESPERION is passionately committed to developing and commercializing oral, LDL-C lowering therapies for patients with hypercholesterolemia.
Click on drug name or indication to see upcoming trial info, prior data, and more general information
Drug | Disease (links)
Stage (next event)
See what the community is saying - click to see full post